Logo image of PLX

PROTALIX BIOTHERAPEUTICS INC (PLX) Stock Analyst Ratings

USA - NYSE Arca - NYSEARCA:PLX - US74365A3095 - Common Stock

2.06 USD
-0.06 (-2.83%)
Last: 1/28/2026, 8:06:32 PM
2.14 USD
+0.08 (+3.88%)
Pre-Market: 1/29/2026, 4:36:44 AM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to PLX. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 12.75. This target is 518.93% above the current price.
  • PLX was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PLX.
  • In the previous month the buy percentage consensus was at a similar level.
  • Only 5 analysts analyzed PLX. So this is just the average opinion of a couple of analysts.
PLX Historical Analyst RatingsPLX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -89 -81 -73 -65 -57 -49 -41 -33 -25 -17 -9 -1 1 2 3 4 5

Price Target & Forecast

Price Low Median Mean High 2.0612.1212.7512.7513.65 - 488.35% 518.93% 518.93% 562.62%
PLX Current Analyst RatingPLX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2025-11-21 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-03 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-31 HC Wainwright & Co. Maintains Buy -> Buy
2021-05-03 HC Wainwright & Co. Maintains Buy

PROTALIX BIOTHERAPEUTICS INC / PLX FAQ

What is the average price target for PROTALIX BIOTHERAPEUTICS INC (PLX) stock?

5 analysts have analysed PLX and the average price target is 12.75 USD. This implies a price increase of 518.93% is expected in the next year compared to the current price of 2.06.


Can you provide the consensus rating for PROTALIX BIOTHERAPEUTICS INC stock?

The consensus rating for PROTALIX BIOTHERAPEUTICS INC (PLX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.